/overview-of-igwg4.tmb-1200v.jpg?sfvrsn=3e911e4e_6)
Global health security took a step forward this week as representatives from World Health Organization (WHO) member states continued negotiations on a critical component of the future of pandemic preparedness: the Pathogen Access and Benefit-Sharing (PABS) system. Discussions, held January 20–22, 2026, centered on finalizing the details of this system, a core element of the historic WHO Pandemic Agreement adopted in May 2025. The aim is to create a framework for the rapid and equitable sharing of pathogens with pandemic potential and the benefits that arise from related research and development, including vaccines, therapeutics, and diagnostics. This ongoing work underscores the international commitment to learning from the inequities and gaps exposed during the COVID-19 pandemic and building a more resilient global health architecture.
The PABS system is intended to address a fundamental challenge in pandemic prevention: ensuring that access to biological materials needed for research and development isn’t hampered by geopolitical barriers or commercial interests. Currently, sharing of pathogens and genetic sequence information can be slow and uneven, hindering the swift development of countermeasures. The WHO Pandemic Agreement, and specifically the PABS system it establishes, seeks to streamline this process, promoting transparency and accountability. The negotiations this week focused on resolving outstanding issues within the draft annex detailing how the system will function in practice, with negotiators aiming to identify areas of consensus and bridge remaining differences. Understanding the WHO Pandemic Agreement is crucial to understanding the context of these negotiations.
Progress and Remaining Challenges in PABS Negotiations
Ambassador Tovar da Silva Nunes, of Brazil, and Mr. Matthew Harpur, of the United Kingdom, co-chairs of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement, expressed cautious optimism following the resumed session. “I am encouraged by the progress we have made in several areas, with signs of emerging consensus for some parts of the Pathogen Access and Benefit‑Sharing system,” Ambassador Nunes stated. Mr. Harpur added that Member States have engaged in “constructive discussions” and demonstrated a “willingness to work together” toward a final agreement. However, both acknowledged that complex issues remain. The focus now shifts to tackling these outstanding challenges in preparation for the May 2026 deadline.
The IGWG was established by the World Health Assembly to specifically draft and negotiate the PABS system. The system aims to enable the safe, transparent, and accountable sharing of pathogens and genetic sequence information. Crucially, it also addresses the fair and equitable sharing of benefits derived from their use. This benefit-sharing component is particularly sensitive, as it involves questions of intellectual property, technology transfer, and access to affordable medical products. The Pandemic Action Network provides further insight into the details of the PABS system.
A Response to Lessons Learned from COVID-19
The impetus for the WHO Pandemic Agreement, and the PABS system within it, stems directly from the experiences of the COVID-19 pandemic. The pandemic highlighted significant inequities in access to vaccines, therapeutics, and diagnostics, with wealthier nations securing the bulk of available supplies while lower-income countries struggled to protect their populations. The slow pace of pathogen sharing also hampered early research efforts. The agreement represents an attempt to address these shortcomings and create a more equitable and effective global response to future pandemics.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, emphasized the importance of a strong PABS system, stating, “A strong Pathogen Access and Benefit‑Sharing system will be a cornerstone of a safer and more equitable world.” He thanked countries for their commitment to “multilateral solutions,” underscoring the need for international cooperation in addressing global health threats. The agreement will officially enter into force 30 days after 60 countries have ratified it, a process that is currently underway.
Next Steps and the May 2026 Deadline
Following the resumed session, further meetings of the IGWG are scheduled in the coming months to continue negotiations. The outcome of this work will be submitted to the Seventy-ninth World Health Assembly in May 2026 for consideration. This timeline is considered critical, as countries aim to have a fully operational PABS system in place before the next potential pandemic emerges. The December 2025 meeting of the IGWG was extended specifically to allow for more time to address these complex issues, demonstrating the commitment of Member States to reaching a consensus.
The successful implementation of the PABS system will require ongoing collaboration and a willingness to compromise from all parties involved. It will also necessitate robust monitoring and enforcement mechanisms to ensure that the system operates effectively and equitably. The coming months will be crucial in determining whether the international community can translate its commitment to pandemic preparedness into concrete action.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or legal advice. It is essential to consult with qualified professionals for any health concerns or before making any decisions related to your health or treatment.
What do you suppose about the progress of the WHO Pandemic Agreement? Share your thoughts in the comments below, and please share this article with your network to assist spread awareness about this important global health initiative.
